Myya is a first-of-its-kind breast cancer recovery platform providing insurance-billable telehealth post-mastectomy fittings, recovery products, and patient navigation. Built for women navigating life after breast surgery, Myya helps patients access the bras, breast forms, and support they have been prescribed without the burden of finding specialized care on their own. The company partners with physicians and hospital systems, combines human expertise with digital tools, and is expanding into AI-powered navigation and breast cancer research. Myya exists to make survivorship care more accessible, personalized, and dignified.

Jasmine Jones is a healthcare entrepreneur, Certified Mastectomy Fitter, and founder and CEO of Myya and Cherry Blossom Intimates. Inspired by her grandmother’s experience with breast cancer, she began her entrepreneurial journey nearly a decade ago after identifying a critical gap between prescribed care and patients’ ability to access it.

Today, Myya has served more than 21,000 patients and partnered with 160+ physicians across hospital systems. Jasmine has raised nearly $3 million and led the company across insurance-billable care, telehealth, hospital integration, custom 3D printing, and AI-powered patient navigation.

As a Johns Hopkins Ward Infinity Fellow, Jasmine developed digital health tools using data analytics and large language models to improve patient identification and outcomes. Her work is now expanding into original breast cancer research and the exploration of genomics and emerging technologies, including the potential application of quantum computing to breast cancer risk identification and precision care.

Recognized by Forbes 30 Under 30 and Washington Business Journal 40 Under 40, Jasmine earned her BBA from Trinity Washington University and is pursuing her MBA.